Philip Steven Low, Ph.D.
Dr. Philip Steven Low did his PhD in Computational Neuroscience at the Salk Institute, which he joined on the recommendation of the late Francis Crick, after completing his undergraduate degree at University of Chicago where he studied Mathematics, Neuroscience, and Physics and invented novel neurosurgical techniques undermining the role Neuroscientists have attributed to the Neocortex. At Harvard Medical School, Dr. Low showed that compound H, a collagen Type I Inhibitor, could successfully neutralize the growth of fibroid tumors. At the Salk, Dr. Low invented the SPEARS algorithm and authored one of the shortest PhD thesis on record: "A New Way To Look At Sleep: Separation & Convergence," a one-page solution to a longstanding problem in brainwave analysis. The experimental and computational methods Dr. Low has developed challenge our understanding of brainwaves during sleeping and awake states in humans and across species. His work has been featured in technical and popular articles including The MIT Technology Review, New Scientist, The Economist, and The New York Times, and has garnered awards from the National Science Foundation, Merck Co., The Ray Thomas Edwards and Kavli Foundations for Innovative Research, as well as five awards from the Sloan and Swartz Foundations. To bring his innovations to the market, Dr. Low founded NeuroVigil, Inc., an award-winning Wireless Neurodiagnostics company, developing the iBrain, a wireless iPod for the brain. NeuroVigil won the 2008 annual Draper Fisher Jurvetson 250KVenture Challenge, the UCSD50K Entrepreneurship Competition and delivered the IN3 MedTech Investment in Medicine Summit Keynote Address back-to-back. Dr. Low is also on the Faculty at the Stanford School of Medicine and MIT.
About NeuroVigil, Inc.
NeuroVigil, Inc. is dedicated to the betterment of the human condition by merging non-invasive wireless brain recording technology with advanced computational analysis techniques and wireless engineering. The company has developed proprietary technology which leverages the dynamic oscillations produced during sleep in order to systematically scan the brain for signs of pathologic activity years in advance of cognitive or behavioral symptoms. The NeuroVigil team is comprised of Dr. Philip low, Founder and CEO, as well as polysomnographers, engineers with industry training, Fortune 500 CEOs and business experts in product development, wireless technology and the transportation industry, six members of the National Academy of Science, and four Nobel laureates. For more information, please visit www.neurovigil.com.